MétaCan
Menu
Back to cohort
Record W4413425700 · doi:10.2196/74010

Patient Attitudes Toward Artificial Intelligence in Cancer Care: Scoping Review

2025· review· en· W4413425700 on OpenAlexaffvenue
Daniel Hilbers, Navid Nekain, Alan Bates, John-Jose Nuñez

Bibliographic record

VenueJMIR Cancer · 2025
Typereview
Languageen
FieldMedicine
TopicArtificial Intelligence in Healthcare and Education
Canadian institutionsBC Cancer AgencyUniversity of British Columbia
Fundersnot available
KeywordsCancerPsychologyMedicineArtificial intelligenceComputer scienceInternal medicine

Abstract

fetched live from OpenAlex

Background: Artificial intelligence is reshaping cancer care, but little is known about how people with cancer perceive its integration into their care. Understanding these perspectives is essential to ensuring artificial intelligence adoption aligns with patient needs and preferences while supporting a patient-centered approach. Objective: The aim of this study is to synthesize existing literature on patient attitudes toward artificial intelligence in cancer care and identify knowledge gaps that can inform future research and clinical implementation. Methods: A scoping review was conducted following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. MEDLINE, Embase, PsycINFO, and CINAHL were searched for peer-reviewed primary research studies published until February 1, 2025. The Population-Concept-Context framework guided study selection, focusing on adult patients with cancer and their attitudes toward artificial intelligence. Studies with quantitative or qualitative data were included. Two independent reviewers screened studies, with a third resolving disagreements. Data were synthesized into tabular and narrative summaries. Results: Our search yielded 1240 citations, of which 19 studies met the inclusion criteria, representing 2114 patients with cancer across 15 countries. Most studies used quantitative methods (9/19, 47%) such as questionnaires or surveys. The most studied cancers were melanoma (375/2114, 17.7%), prostate (n=323, 15.3%), breast (n=263, 12.4%), and colorectal cancer (n=251, 11.9%). Although patients with cancer generally supported artificial intelligence when used as a physician-guided tool (9/19, 47%), concerns about depersonalization, treatment bias, and data security highlighted challenges in implementation. Trust in artificial intelligence (10/19, 53%) was shaped by physician endorsement and patient familiarity, with greater trust when artificial intelligence was physician-guided. Geographic differences were observed, with greater artificial intelligence acceptance in Asia, while skepticism was more prevalent in North America and Europe. Additionally, patients with metastatic cancer (99/2114, 5%) were underrepresented, limiting insights into artificial intelligence perceptions in this population. Conclusions: This scoping review provides the first synthesis of patient attitudes toward artificial intelligence across all cancer types and highlights concerns unique to patients with cancer. Clinicians can use these findings to enhance patient acceptance of artificial intelligence by positioning it as a physician-guided tool and ensuring its integration aligns with patient values and expectations.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.629
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0020.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.363
GPT teacher head0.585
Teacher spread0.222 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJMIR CancerSame topicArtificial Intelligence in Healthcare and EducationFrench-language works237,207